Here are three things to know:
1. The patent application has cleared internal review and is now awaiting patent issuance.
2. The patent encompasses treatment methods of compression or contusion spinal cord injuries with a variety of biodegradable or bioabsorbable polymeric implants including the Neuro-Spinal Scaffold.
3. InVivo is the excusive licensee of this intellectual property through a license with Boston Children’s Hospital and Cambridge-based Massachusetts Institute of Technology.
More articles on devices:
MiMedx files lawsuit against Osiris Therapeutics — 4 things to know
Blue Belt Technologies co-founder wins outstanding entrepreneur award: 5 things to know
Novastep, Vivex Biomedical partner: 4 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
